Product NDC: | 33342-029 |
Proprietary Name: | Donepezil Hydrochloride |
Non Proprietary Name: | Donepezil Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Donepezil Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 33342-029 |
Labeler Name: | Macleods Pharmaceuticals Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201146 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121214 |
Package NDC: | 33342-029-07 |
Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (33342-029-07) |
NDC Code | 33342-029-07 |
Proprietary Name | Donepezil Hydrochloride |
Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (33342-029-07) |
Product NDC | 33342-029 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Donepezil Hydrochloride |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20121214 |
Marketing Category Name | ANDA |
Labeler Name | Macleods Pharmaceuticals Limited |
Substance Name | DONEPEZIL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |